Sigma-Tau Pharma Limited Newsroom

The Sigma-Tau Newsroom is the single location to learn latest developments about the company, its research, as well as important discoveries in the understanding and treatment of rare diseases.

News Release - February 15, 2007 - FDA grants Sigma-Tau Pharmaceuticals, Inc. the Orphan Drug Designation for Chenodeoxycholic Acid (CDCA) for the treatment of Cerebrotendinous Xanthomatosis (CTX)

News Release - January 15, 2007 - Brian Schreiber, M.D. joins Sigma-Tau Pharmaceuticals, Inc. as Vice President of Medical Affairs

Press Release - January 04, 2007 - DOR BioPharma Receives $3 Million From Sigma-Tau Pharmaceuticals for Exclusive Right to Negotiate orBec(R) Strategic Alliance

Press Release - March 30, 2006 - Sigma-Tau strengthens with Banca Intesa(.pdf)